BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15116098)

  • 1. Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene.
    EL Naaman C; Grum-Schwensen B; Mansouri A; Grigorian M; Santoni-Rugiu E; Hansen T; Kriajevska M; Schafer BW; Heizmann CW; Lukanidin E; Ambartsumian N
    Oncogene; 2004 Apr; 23(20):3670-80. PubMed ID: 15116098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activator of metastasis in cancer cells, Mst1/S100A4 protein binds to tumor suppressor protein p53].
    Grigorian M; Lukanidin E
    Genetika; 2003 Jul; 39(7):900-8. PubMed ID: 12942774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.
    Luo JL; Yang Q; Tong WM; Hergenhahn M; Wang ZQ; Hollstein M
    Oncogene; 2001 Jan; 20(3):320-8. PubMed ID: 11313961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction.
    Grigorian M; Andresen S; Tulchinsky E; Kriajevska M; Carlberg C; Kruse C; Cohn M; Ambartsumian N; Christensen A; Selivanova G; Lukanidin E
    J Biol Chem; 2001 Jun; 276(25):22699-708. PubMed ID: 11278647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice.
    Bouvard V; Zaitchouk T; Vacher M; Duthu A; Canivet M; Choisy-Rossi C; Nieruchalski M; May E
    Oncogene; 2000 Feb; 19(5):649-60. PubMed ID: 10698510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
    Burns TF; Bernhard EJ; El-Deiry WS
    Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas.
    Bukholm IK; Nesland JM
    Virchows Arch; 2000 Mar; 436(3):224-8. PubMed ID: 10782880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
    Kanavaros P; Stefanaki K; Rontogianni D; Papalazarou D; Sgantzos M; Arvanitis D; Vamvouka C; Gorgoulis V; Siatitsas I; Agnantis NJ; Bai M
    Histol Histopathol; 2001 Oct; 16(4):1005-12. PubMed ID: 11642719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential post-transcriptional regulation of p21WAF1/Cip1 levels in the developing nervous system following gamma-irradiation.
    Herzog KH; Braun JS; Han SH; Morgan JI
    Eur J Neurosci; 2002 Feb; 15(4):627-36. PubMed ID: 11886443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
    Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
    Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
    Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V
    Oncogene; 2000 Jul; 19(31):3498-507. PubMed ID: 10918608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific induction of p53 targets in vivo.
    Fei P; Bernhard EJ; El-Deiry WS
    Cancer Res; 2002 Dec; 62(24):7316-27. PubMed ID: 12499275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
    Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
    Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the cell cycle regulatory genes p16INK4A and p21WAF1 and the metastasis-inducing gene S100A4 are infrequent and unrelated to p53 tumour suppressor gene status and data on survival in oropharyngeal squamous cell carcinomas.
    Ibrahim SO; Lillehaug JR; Vasstrand EN
    Anticancer Res; 2003; 23(6C):4593-600. PubMed ID: 14981901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
    Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
    Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene.
    Wu L; Levine AJ
    Mol Med; 1997 Jul; 3(7):441-51. PubMed ID: 9260156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
    Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.